Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 2.90% | |
| Calm After Storm | Range Contraction | 10.00% | |
| Wide Bands | Range Expansion | 10.00% | |
| Shooting Star Candlestick | Bearish | 6.57% | |
| Calm After Storm | Range Contraction | 6.57% | |
| Wide Bands | Range Expansion | 6.57% | |
| Calm After Storm | Range Contraction | 8.50% | |
| Wide Bands | Range Expansion | 8.50% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 11 hours ago |
| Rose Above 20 DMA | about 12 hours ago |
| 60 Minute Opening Range Breakout | about 12 hours ago |
| Rose Above Previous Day's High | about 12 hours ago |
| Up 5% | about 12 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Entheogens Chronic Pain Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants Synthetic Cannabinoids Tetrahydrocannabinol
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Entheogens Chronic Pain Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants Synthetic Cannabinoids Tetrahydrocannabinol
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.9799 |
| 52 Week Low | 3.0 |
| Average Volume | 130,485 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 4.96 |
| 10-Day Moving Average | 4.31 |
| Average True Range | 0.76 |
| RSI (14) | 43.82 |
| ADX | 16.66 |
| +DI | 24.49 |
| -DI | 18.56 |
| Chandelier Exit (Long, 3 ATRs) | 4.49 |
| Chandelier Exit (Short, 3 ATRs) | 5.28 |
| Upper Bollinger Bands | 6.87 |
| Lower Bollinger Band | 3.06 |
| Percent B (%b) | 0.45 |
| BandWidth | 76.84 |
| MACD Line | -0.48 |
| MACD Signal Line | -0.54 |
| MACD Histogram | 0.0635 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.51 | ||||
| Resistance 3 (R3) | 5.49 | 5.24 | 5.39 | ||
| Resistance 2 (R2) | 5.24 | 5.06 | 5.25 | 5.34 | |
| Resistance 1 (R1) | 5.01 | 4.95 | 5.13 | 5.03 | 5.30 |
| Pivot Point | 4.76 | 4.76 | 4.82 | 4.77 | 4.76 |
| Support 1 (S1) | 4.53 | 4.58 | 4.65 | 4.55 | 4.27 |
| Support 2 (S2) | 4.28 | 4.47 | 4.29 | 4.23 | |
| Support 3 (S3) | 4.05 | 4.28 | 4.19 | ||
| Support 4 (S4) | 4.07 |
